JP2005538930A - ヒトfoxc2タンパク質およびfoxc−2相互作用タンパク質の複合体 - Google Patents

ヒトfoxc2タンパク質およびfoxc−2相互作用タンパク質の複合体 Download PDF

Info

Publication number
JP2005538930A
JP2005538930A JP2003564087A JP2003564087A JP2005538930A JP 2005538930 A JP2005538930 A JP 2005538930A JP 2003564087 A JP2003564087 A JP 2003564087A JP 2003564087 A JP2003564087 A JP 2003564087A JP 2005538930 A JP2005538930 A JP 2005538930A
Authority
JP
Japan
Prior art keywords
foxc2
polypeptide
seq
protein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003564087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538930A5 (cg-RX-API-DMAC7.html
Inventor
イサベル・クリメント−ヨハンソン
スヴェン・エナーベック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LeanGene AB
Original Assignee
LeanGene AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200265A external-priority patent/SE0200265D0/xx
Application filed by LeanGene AB filed Critical LeanGene AB
Publication of JP2005538930A publication Critical patent/JP2005538930A/ja
Publication of JP2005538930A5 publication Critical patent/JP2005538930A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2003564087A 2002-01-29 2003-01-28 ヒトfoxc2タンパク質およびfoxc−2相互作用タンパク質の複合体 Pending JP2005538930A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200265A SE0200265D0 (sv) 2002-01-29 2002-01-29 Protein complexes
US37734902P 2002-04-30 2002-04-30
PCT/SE2003/000139 WO2003064467A1 (en) 2002-01-29 2003-01-28 A complex of a human foxc2 protein and a foxc2-interacting protein

Publications (2)

Publication Number Publication Date
JP2005538930A true JP2005538930A (ja) 2005-12-22
JP2005538930A5 JP2005538930A5 (cg-RX-API-DMAC7.html) 2006-03-16

Family

ID=27667646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564087A Pending JP2005538930A (ja) 2002-01-29 2003-01-28 ヒトfoxc2タンパク質およびfoxc−2相互作用タンパク質の複合体

Country Status (4)

Country Link
US (1) US7217692B2 (cg-RX-API-DMAC7.html)
EP (1) EP1468017A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005538930A (cg-RX-API-DMAC7.html)
WO (1) WO2003064467A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540586A (ja) * 2005-05-18 2008-11-20 フォルシュングスフェアブント ベルリン エー ファウ Akap−pka相互作用の非ペプチド阻害剤

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005099363A2 (en) 2004-03-26 2005-10-27 Whitehead Institute For Biomedical Research Methods of diagnosing, preventing and treating cancer metastasis
WO2008086090A1 (en) * 2007-01-05 2008-07-17 University Of Washington Self-assembled heterogeneous integrated optical analysis system
US8579434B2 (en) 2007-11-07 2013-11-12 University Of Washington Through Its Center For Commercialization Free-standing two-sided device fabrication
US11235062B2 (en) * 2009-03-06 2022-02-01 Metaqor Llc Dynamic bio-nanoparticle elements
US11096901B2 (en) 2009-03-06 2021-08-24 Metaqor Llc Dynamic bio-nanoparticle platforms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
WO2001060853A1 (en) * 2000-02-18 2001-08-23 Biovitrum Ab Transgenic animal model for obesity expressing foxc2
AU2001292481A1 (en) * 2000-09-26 2002-04-08 Leangene Ab Promoter sequences

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540586A (ja) * 2005-05-18 2008-11-20 フォルシュングスフェアブント ベルリン エー ファウ Akap−pka相互作用の非ペプチド阻害剤

Also Published As

Publication number Publication date
WO2003064467A1 (en) 2003-08-07
US20060052293A1 (en) 2006-03-09
EP1468017A1 (en) 2004-10-20
US7217692B2 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
US20250283871A1 (en) Compositions and methods for modulating the interaction between ss18-ssx fusion oncoprotein and nucleosomes
WO2001009317A1 (fr) Gene associe au cancer de l'estomac
JP2000078991A (ja) ヒト・ナトリウム依存性リン酸輸送体(ipt―1)
JP2002521055A (ja) 98個のヒト分泌タンパク質
CN1093406A (zh) 可分离的编码肿瘤排斥抗原前体的核酸序列
JP2001508656A (ja) ヒトmage様タンパク質
JP2001527524A (ja) ヒト乳房腫瘍特異性タンパク質
US6323329B1 (en) Nucleic acid sequences of genes encoding high mobility group proteins
JP2003524366A (ja) 64個のヒト分泌タンパク質
US7217692B2 (en) Complex of a human FOXC2 protein and a FOXC2-interacting protein
US6043084A (en) Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer
US20020086384A1 (en) Splice variants of oncogenes
JP2003521215A (ja) 83個のヒト分泌タンパク質
JP2001511645A (ja) ヒトC5a様受容体
US7087717B2 (en) Sp110, a polypeptide component of the nuclear body
JP2001501802A (ja) ハンチンチン(huntingtin)結合蛋白質
US20020142003A1 (en) Tumor-associated antigen (B345)
EP1428891A1 (en) Novel gene nedl-1
CN100393745C (zh) 一种肿瘤抗原蛋白质和肿瘤抗原肽
JP2002527028A (ja) ヒトアポトーシス調節タンパク質
JP2001527522A (ja) ヒトgタンパク質シグナル伝達制御因子(hrgs)
JP2001509015A (ja) ヒト塩素イオンチャネルタンパク質(hccp)
WO2001060855A1 (fr) Nouvelle proteine humaine associee a la regulation du cycle cellulaire et sa sequence de codage
JP2001512968A (ja) ヒトp24小胞タンパク質
JPH1132782A (ja) Ynl075w/htxft19ポリヌクレオチドおよびポリペプチド

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090331